
Ardent Health (ARDT) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
1.5B
Gross Profit
1.2B
82.71%
Operating Income
67.1M
4.48%
Net Income
59.0M
3.94%
EPS (Diluted)
$0.29
Balance Sheet Metrics
Total Assets
4.9B
Total Liabilities
3.3B
Shareholders Equity
1.6B
Debt to Equity
2.14
Cash Flow Metrics
Operating Cash Flow
21.3M
Free Cash Flow
-47.7M
Revenue & Profitability Trend
Ardent Health Income Statement From 2018 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2018 |
---|---|---|---|---|---|
Revenue | 6.0B | 5.4B | 5.1B | 4.9B | 4.1B |
Cost of Goods Sold | 1.0B | - | - | - | - |
Gross Profit | 4.9B | - | - | - | - |
Gross Margin % | 82.7% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 3.9B | 3.6B | 3.4B | 3.1B | 2.7B |
Other Operating Expenses | 496.2M | 1.4B | 1.4B | 1.2B | 1.1B |
Total Operating Expenses | 4.4B | 5.1B | 4.8B | 4.3B | 3.8B |
Operating Income | 405.8M | 209.4M | 217.0M | 436.6M | 149.8M |
Operating Margin % | 6.8% | 3.9% | 4.2% | 9.0% | 3.7% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 65.6M | 65.4M | 82.1M | 93.8M | 108.6M |
Other Non-Operating Income | 22.9M | -287.0K | 176.5M | -46.8M | -48.1M |
Pre-tax Income | 363.1M | 143.7M | 311.5M | 295.9M | -6.9M |
Income Tax | 63.4M | 20.8M | 46.1M | 51.3M | 16.0M |
Effective Tax Rate % | 17.4% | 14.5% | 14.8% | 17.3% | 0.0% |
Net Income | 299.7M | 122.9M | 265.4M | 244.6M | -22.9M |
Net Margin % | 5.0% | 2.3% | 5.2% | 5.0% | -0.6% |
Key Metrics | |||||
EBITDA | 578.3M | 351.9M | 531.7M | 579.9M | 293.9M |
EPS (Basic) | $1.59 | $0.36 | $1.34 | $1.09 | -$0.49 |
EPS (Diluted) | $1.58 | $0.36 | $1.34 | $1.09 | -$0.49 |
Basic Shares Outstanding | 132439695 | 140963328 | 140963328 | 140963328 | 140963328 |
Diluted Shares Outstanding | 132439695 | 140963328 | 140963328 | 140963328 | 140963328 |
Income Statement Trend
Ardent Health Balance Sheet From 2017 to 2024
Metric | 2024 | 2023 | 2022 | 2018 | 2017 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 556.8M | 437.6M | 456.1M | 59.7M | 72.0M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 743.0M | 775.5M | 603.4M | 529.1M | 453.8M |
Inventory | 115.1M | 105.5M | 107.2M | 84.8M | 84.2M |
Other Current Assets | 304.1M | 222.3M | 173.6M | 78.2M | 66.8M |
Total Current Assets | 1.8B | 1.6B | 1.4B | 838.1M | 736.4M |
Non-Current Assets | |||||
Property, Plant & Equipment | 2.4B | 2.3B | 2.3B | 691.1M | 501.0M |
Goodwill | 1.8B | 1.8B | 1.8B | 1.7B | 1.7B |
Intangible Assets | 76.9M | 76.9M | 76.9M | 77.8M | 78.3M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 155.3M | 179.6M | 157.8M | 146.1M | 150.1M |
Total Non-Current Assets | 3.1B | 3.1B | 3.1B | 1.9B | 1.6B |
Total Assets | 5.0B | 4.7B | 4.5B | 2.7B | 2.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 401.2M | 474.5M | 320.8M | 230.4M | 226.5M |
Short-term Debt | 55.6M | 61.0M | 58.4M | 9.0M | 16.9M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | 7.2M | 8.0M | - |
Total Current Liabilities | 945.4M | 994.1M | 808.6M | 555.2M | 507.3M |
Non-Current Liabilities | |||||
Long-term Debt | 2.2B | 2.3B | 2.3B | 1.3B | 935.8M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 261.7M | 76.0M | 72.5M | 39.0M | 45.3M |
Total Non-Current Liabilities | 2.5B | 2.7B | 2.6B | 1.4B | 1.1B |
Total Liabilities | 3.4B | 3.6B | 3.4B | 2.0B | 1.6B |
Equity | |||||
Common Stock | - | - | - | - | - |
Retained Earnings | 365.8M | 155.5M | 101.5M | -119.9M | -24.1M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.5B | 1.1B | 1.1B | 759.1M | 760.3M |
Key Metrics | |||||
Total Debt | 2.3B | 2.4B | 2.4B | 1.3B | 952.7M |
Working Capital | 887.3M | 624.0M | 600.7M | 282.9M | 229.1M |
Balance Sheet Composition
Ardent Health Cash Flow Statement From 2018 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2018 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 299.7M | 129.0M | 265.4M | 244.6M | -103.3M |
Depreciation & Amortization | 146.3M | 140.8M | 138.2M | 137.2M | 143.2M |
Stock-Based Compensation | 18.0M | 904.0K | 611.0K | 549.0K | 3.7M |
Working Capital Changes | -73.3M | -42.6M | 804.0K | -65.7M | 27.1M |
Operating Cash Flow | 415.5M | 237.1M | -20.3M | 120.7M | 69.7M |
Investing Activities | |||||
Capital Expenditures | -187.5M | -137.4M | -151.1M | -139.0M | -160.7M |
Acquisitions | -31.2M | 0 | 206.4M | -2.3M | -349.8M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -220.5M | -138.0M | 46.6M | -139.8M | -500.6M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | 0 | 0 | -174.8M | -62.1M | - |
Debt Issuance | 3.6M | 6.6M | 878.0K | 1.2B | 1.6B |
Debt Repayment | -108.4M | -138.6M | -17.3M | -1.3B | -1.4B |
Financing Cash Flow | 24.6M | -227.3M | -270.3M | -283.9M | 141.3M |
Free Cash Flow | 127.5M | 84.3M | -189.5M | 7.9M | -1.1M |
Net Change in Cash | 219.7M | -128.2M | -244.1M | -303.0M | -289.7M |
Cash Flow Trend
Ardent Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
7.13
Forward P/E
5.99
Price to Book
1.46
Price to Sales
0.28
PEG Ratio
5.99
Profitability Ratios
Profit Margin
3.73%
Operating Margin
4.48%
Return on Equity
23.35%
Return on Assets
5.22%
Financial Health
Current Ratio
2.12
Debt to Equity
145.79
Per Share Data
EPS (TTM)
$1.68
Book Value per Share
$8.22
Revenue per Share
$44.32
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
ardt | 1.7B | 7.13 | 1.46 | 23.35% | 3.73% | 145.79 |
HCA Healthcare | 87.0B | 16.05 | -201.13 | 1,605.77% | 8.07% | -106.02 |
Tenet Healthcare | 16.3B | 11.23 | 3.89 | 28.82% | 7.09% | 152.20 |
Pacs | 1.9B | 20.07 | 3.26 | 110.96% | 2.59% | 469.36 |
Select Medical | 1.8B | 23.21 | 1.07 | 7.72% | 3.33% | 136.22 |
Brookdale Senior | 1.8B | - | 12.44 | -90.69% | -7.87% | 3,778.18 |
Financial data is updated regularly. All figures are in the company's reporting currency.